Actively Recruiting
School-based Treatment of Social Anxiety With Developmentally Oriented Cognitive Therapy for Social Anxiety Disorder
Led by Klaus Ranta · Updated on 2024-07-08
156
Participants Needed
1
Research Sites
301 weeks
Total Duration
On this page
Sponsors
K
Klaus Ranta
Lead Sponsor
U
University of Helsinki
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this randomized controlled trial is to find out whether the brief, 10-session Developmentally Oriented Cognitive Therapy for Social Anxiety Disorder (DOCT-SAD) is more effective than standard counseling (SC) to treat Social Anxiety Disorder (SAD) among 12 to 17-year-old adolescents with SAD. Potential participants for the study are identified from school health and well-being services (SHWS). The DOCT-SAD is delivered by method-trained school psychologists working in the SHWS. SC will be provided by non-method-trained SHWS professionals (i.e. school nurses, social workers or school psychologists) according to their routine counselling practice. The main research questions of the study are: 1. Is DOCT-SAD more effective than SC for alleviating symptoms of social anxiety? 2. Is DOCT-SAD more effective than SC to produce diagnostic remission from primary SAD and alleviating symptom severity associated with SAD? 3. Is DOCT-SAD more effective than SC for alleviating co-occurring depressive symptoms, interference in daily functioning due to worry or fears, and for increasing general well-being, positive mental health, and for improving the quality of life among adolescents with SAD? Researchers will compare DOCT-SAD with SC to see if DOCT-SAD is effective in the treatment of SAD in adolescents. Participants will: * be treated either with DOCT-SAD or SC for 10 weeks. * be followed up and assessed clinically at six-month and twelve-month follow-up points.
CONDITIONS
Official Title
School-based Treatment of Social Anxiety With Developmentally Oriented Cognitive Therapy for Social Anxiety Disorder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 13 to 17 years
- Diagnosis of primary Social Anxiety Disorder according to DSM-5
- Social Anxiety Disorder is the main mental health condition
- Motivation of adolescent and parent to participate in DOCT-SAD or SC as described
- Good command of the Finnish language
You will not qualify if you...
- Intellectual disability
- Primary autism spectrum disorder
- Marked psychotic symptoms or psychotic disorder
- Severe eating disorder, depression, or other anxiety disorder needing urgent treatment
- Acute suicidality or suicide risk
- Substance use or substance use disorder requiring child protection measures
- Environmental or contextual risk factors requiring child protection measures
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tampere University
Tampere, Pirkanmaa, Finland, 33014
Actively Recruiting
Research Team
K
Klaus Ranta, MD, PhD
CONTACT
S
Siiri Lampela, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here